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 2 
Abstract 26 
Cerebrospinal fluid (CSF) analysis is commonly used in the diagnostic investigation of 27 
seizure disorders in order to exclude possible inflammatory underlying aetiology. 28 
The medical records were searched for dogs presenting with epileptic seizures (ES) that 29 
had normal interictal neurological examination, normal complete blood count and biochemistry 30 
analysis, unremarkable magnetic resonance imaging of the brain and had CSF analysis 31 
performed as part of the diagnostic investigation.  32 
 A total of 200 dogs met the inclusion criteria. The CSF was abnormal in 30 dogs with 33 
a median total nucleated cell count of 2 cells/µl (IQR 1.5-6) and median protein concentration 34 
of 0.37g/l (IQR 0.31-0.41). Pleocytosis was recorded in 14/30 dogs and the CSF protein was 35 
increased in 22/30. There was no correlation between abnormal CSF and the type or number of 36 
seizures or the time interval between the last seizure and CSF collection. A significant 37 
correlation was found between the number of red blood cells on CSF and having an abnormal 38 
CSF. The prevalence of having a diagnosis other than suspected idiopathic epilepsy (IE) was 39 
0.5% (1/200).  40 
These results suggest that performing CSF analysis in dogs with recurrent ES that have 41 
normal interictal neurological examination and unremarkable MRI has a low diagnostic value.  42 
 3 
Introduction 43 
Epileptic seizures are the most common chronic neurological condition in dogs.1 Epilepsy is a 44 
complex disease of the brain characterised by an enduring predisposition to generate epileptic 45 
seizures and is practically defined as having at least two unprovoked epileptic seizures >24 h 46 
apart. According to its aetiology, it can be classified into idiopathic epilepsy (IE), whereby an 47 
underlying cause for the epileptic seizures (ES) cannot be found or structural epilepsy, in which 48 
there is an underlying intracranial pathology.2 Reactive seizures occur in response to a transient 49 
disturbance in function (metabolic or toxic in nature), which is reversible when the cause or 50 
disturbance is rectified.2 The prevalence of idiopathic epilepsy in the general canine population 51 
of the United Kingdom (UK) has been reported as 0.62%.3 52 
Diagnosing IE is achieved by excluding other possible causes of ES. The minimum 53 
criteria for a Tier I confidence level diagnosis of IE includes confirmation of two or more 54 
unprovoked ES 24 h apart, an onset of the episodes between 6 months of age and 6 years, an 55 
interictal period exempt of neurological deficits and non-clinically significant abnormalities on 56 
minimum database blood tests and urinalysis.4 A Tier II confidence level for the diagnosis of 57 
IE is attributed when structural epilepsy has also been excluded through magnetic resonance 58 
imaging (MRI) of the brain, CSF analysis and unremarkable fasting and post-prandial bile acid 59 
stimulation test.4 Financial considerations and owner preference to avoid potentially more 60 
invasive procedures (such as general anaesthesia and CSF collection) can dictate investigation, 61 
and in such cases, the ability to suggest a diagnosis prior to further investigations is valuable.  62 
Previous studies have shown that the neurological examination alone is a good predictor 63 
for an abnormal MRI in epileptic dogs.5 6 7 The studies have suggested that the sensitivity for 64 
finding abnormalities on MRI in dogs without interictal neurological deficits is low and that 65 
this test may not always be essential in dogs less than 6y old 6. 66 
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The value of performing CSF collection and analysis in dogs with suspected IE, after 67 
reactive seizures and structural abnormalities on MRI have been excluded, has not yet been 68 
determined. The aim of this study was therefore to determine the value of performing CSF 69 
analysis in a population of dogs with normal neurological examination in the interictal period, 70 
unremarkable haematology and biochemistry and MRI of the brain.  71 
 72 
Materials and methods 73 
The medical records from the Neurology and Neurosurgery service of the Small Animal 74 
Teaching Hospital (SATH) of the University of Liverpool between 2010 and 2015 were 75 
reviewed retrospectively to identify dogs presented for investigation of ES. The study protocol 76 
was approved by the University of Liverpool’s Veterinary Research Ethics Committee 77 
(VREC263).  78 
Inclusion criteria were that the patients had (1) presented for investigation of ES, (2) 79 
unremarkable interictal neurological examination performed by either a board-certified, board 80 
eligible neurologists or residents, (3) normal complete blood count (CBC), normal biochemistry 81 
profile (or clinically non-significant biochemistry alterations), (4) normal MRI of the brain and 82 
(5) cerebrospinal fluid (CSF) analysis performed. Data related to signalment, age at ES onset, 83 
ES semiology (focal or generalised), presentation of cluster seizures (defined as 2 or more ES 84 
within a 24h period) or status epilepticus (ES which shows no signs of arresting after a duration 85 
encompassing the great majority of ES of that type, defined clinically as greater than 5 minutes), 86 
and number of ES episodes prior to investigation were documented.  The time interval between 87 
the last ES and collection of CSF was also recorded. For statistical analysis, the dogs were 88 
divided into three groups according to a previous publication8: length of time between their last 89 
ES and the CSF collection up to 48 hours (group 1); between 3 and 7 days (group 2) and over 90 
7 days (group 3). 91 
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Diagnostic investigation in all cases included a CBC and serum biochemistry profile 92 
(sodium, potassium, chloride, calcium, phosphate, alanine aminotransferase, alkaline 93 
phosphatise, total bilirubin, urea, creatinine, total protein, albumin, glucose, cholesterol and 94 
triglycerides). A bile acid stimulation test and/or fasting ammonia concentration and abdominal 95 
ultrasonography were performed when hepatic encephalopathy was clinically suspected. 96 
Neospora caninum and Toxoplasma gondii antibody titres were tested in some cases. Dogs were 97 
excluded from the study if corticosteroids had been administered in the 7 days prior to 98 
presentation.   99 
Magnetic resonance imaging was performed in all cases under general anaesthesia using 100 
a 1T (Siemens Magnetom, Erlangen, Germany) scanner. As a minimum, the following 101 
sequences were used: T2-weighted images (T2W) (in transverse, sagittal and dorsal planes), 102 
fluid attenuation inversion recovery (FLAIR) and pre and post-contrast (intravenous injection 103 
of 0.1mmol/kg of gadopentetate dimeglubine) T1-weighted images (T1W) in the transverse 104 
plane. A board-certified neurologist (RG) and a board-certified radiologist (TWM) examined 105 
all images and dogs with imaging abnormalities were excluded from the study.  106 
The CSF collection was performed under the same general anaesthesia from either the 107 
cerebellomedullary cistern (CMC) or lumbar subarachnoid space (LSS) after advanced 108 
imaging; samples were collected into a plain plastic and EDTA tubes. The analysis was 109 
performed within one hour of collection and comprised a red blood cell (RBC) count and total 110 
nucleated cell count (TNCC), protein concentration measurement and a cytological 111 
examination with a differential cell count. The CSF samples with blood contamination of 112 
>5000RBC/μl were excluded from the study.  113 
Results of CSF analysis were considered abnormal when the protein concentration was 114 
>0.30g/l (CMC) or >0.45g/l (LSS) or the TNCC was >5cells/μl.9 In the cases where blood 115 
contamination was present, formulae for CSF protein concentration and TNCC correction 116 
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previously reported were used to investigate the possible impact of the blood contamination on 117 
CSF analysis: the TNCC was increased by 1 nucleated cell/μl for every 500 RBC/μl10 and the 118 
protein concentration was increased by 0.01g/L for every 1,000 RBC/μl of CSF.11 The CBC 119 
results were also recorded in order to evaluate the influence of the CBC RBC and white blood 120 
cell (WBC) counts on the CSF results. The referring veterinarians of the patients that presented 121 
abnormal CSF results were contacted via telephone call for a progress update on the long-term 122 
outcome of these cases. 123 
The sample size calculations indicated a total of 195-245 dogs would be required to 124 
estimate the prevalence with a precision of 5% and 95% confidence. All statistical analyses 125 
were performed with Minitab 14 (Minitab Inc. State College, Pennsylvania, USA) and R (“The 126 
R Project”, https://www.r-project.org). Descriptive statistics were computed for variables 127 
where appropriate; continuous data were summarised as median values with interquartile ranges 128 
(IQR), and categorical data were expressed as frequencies with 95% confidence intervals (95% 129 
CI). For categorical variables with a large number of categories and/or categories comprising 130 
only small numbers, groups were pooled into appropriate larger classes. For continuous 131 
variables normality of distribution was assessed graphically and using the Kolmogorov-132 
Smirnov test. Associations between having an abnormal CSF analysis and categorical variables 133 
were assessed using Pearson’s Chi square or Fisher’s exact test, and associations with 134 
continuous variables were assessed using the Mann-Whitney U-test. The relationship between 135 
selected continuous variables was evaluated using Spearman’s rank correlation coefficient, in 136 
order to assess if increases in CSF blood contamination were associated with increases or 137 
decreases in CSF parameters or CBC parameters. For all analyses P<0.05 was considered 138 
significant. 139 
 140 
Results 141 
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A total of 200 dogs with a history of ES and normal interictal neurological examination 142 
were included.  143 
The CBC was normal in all cases. Biochemical abnormalities were found in 6 dogs and 144 
were mainly related to mild increment in liver enzymes (particularly serum alkaline 145 
phosphatase); 3/6 cases were receiving phenobarbitone. Serology antibody titres for 146 
Toxoplasma gondii and Neospora caninum were performed in 23/200 (11.5%) cases and were 147 
negative in all cases.  148 
The majority of dogs were male (62.5%). The most prevalent breeds were: crossbreed 149 
(14.5%), Labrador retriever (8.5%), Border collie (8.5%) and Staffordshire bull terrier (5.5%). 150 
Median age at ES onset was 43.5 months (IQR 25-154) with 22 dogs (11%) <1y old, 130 dogs 151 
(65%) between 1y-6y and 48 dogs (24%) >6y old. Sixty-seven dogs (33.5%) presented focal 152 
ES and 133 dogs (66.5%) generalised ES according to the owners’ description. Cluster seizures 153 
were reported in 57 dogs (28.5%) and only 2 dogs (1%) had a previous episode of status 154 
epilepticus. Of the total population, 90 (45%) dogs suffered from ≤ 5 ES episodes prior to 155 
investigations and 110 (55%) of dogs had > 5 ES episodes recorded. The time interval between 156 
CSF collection and last ES episode was <2 days in 45 dogs (22.5%); between 3-7 days in 55 157 
dogs (27.5%) and >7 days in 100 cases (50%). 158 
The CSF samples were collected via CMC in 196 cases (98%) and LSS in 4 cases (2%). 159 
The median CSF RBC count was 1.5 (IQR 1.5-40) cells/µl, median TNCC was 1.5 cells/µl 160 
(IQR 1.5-2) and median protein concentration was 0.2 g/l (IQR 0.17- 0.26). 161 
The CSF analysis was abnormal in 30 dogs (15%, 95% CI 0.11 – 0.21). For the abnormal 162 
cases, the median CSF RBC count was 40 cells/µl (IQR 2-360), median TNCC was 2 cells/µl 163 
(IQR 1.5-6) and median protein concentration was 0.37g/l (IQR 0.31-0.41). Of these, 1 dog had 164 
a history of status epilepticus and 6 dogs had cluster seizures reported. In 14/30 cases 165 
pleocytosis was identified with a median TNCC of 6 cells/µl (IQR 6-8). The samples were 166 
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collected from CMC in 13 dogs and in 1 dog from the LSS. The differential cell count of patients 167 
with pleocytosis revealed mononuclear predominance in all cases. 168 
The CSF protein was increased in 22/30 dogs of which 21 had been sampled from the 169 
CMC and 1 from the LSS. The median value for abnormal CSF protein concentration collected 170 
from the CMC was 0.4g/l (IQR 0.36-0.42) and 0.46g/l on the case collected from the LSS. Both 171 
pleocytosis and raised CSF protein concentration were present in 6/30 cases and 172 
albuminocytological dissociation was present in 16/30 dogs.  173 
The majority of dogs (16/30) with abnormal CSF had a time interval between the last 174 
ES and CSF analysis >7 days and 8/30 had CSF collected <2 days since the last ES. Twelve 175 
dogs with abnormal CSF analysis had suffered more than 5 ES prior to examination.  176 
Associations between having an abnormal CSF and multiple independent variables were 177 
assessed (Table 1). The only significant correlation found was between the number of RBCs on 178 
CSF and having an abnormal CSF result (Mann-Whitney Test p<0.000). In only one of these 179 
cases the CSF analysis would have become normal after applying correctional formulae. In this 180 
case with albuminocytological dissociation (CSF collected via LSS), the RBC count was 1470 181 
cells/µl.  182 
The correlations between the CSF parameters and blood contamination were further 183 
examined (Table 2). Significant correlations between the blood contamination and the CSF 184 
TNCC and CSF protein were found. These correlations were moderate for CSF TNCC and 185 
weak for CSF protein concentration. When using the formulae for correction of blood 186 
contamination, the correlation between blood contamination and CSF TNCC weakened. To 187 
evaluate whether CBC parameters could influence CSF analysis through blood contamination, 188 
correlations between CBC WBC and RBC counts and the CSF TNCC and RBC count were 189 
assessed using Spearman’s rank correlation coefficient (Table 3). Only a weak correlation 190 
between CBC WBC count and CSF TNCC was found. 191 
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Long-term follow-up information was collected via telephone conversation with the 192 
referring veterinarians of the dogs with abnormal CSF analysis. Follow up was available in 193 
26/30 dogs, with the remaining 4 cases lost to follow up. The median follow-up time for these 194 
cases was 32 months (range 12-60 months). The majority of dogs (20/26) showed improvement 195 
of the ES frequency with anti-epileptic medication and did not develop any neurological 196 
abnormalities. Three other dogs died from unrelated causes namely severe osteoarthritis, 197 
leukaemia and sudden death; the latter had been free of ES for 8 months (on maintenance 198 
treatment with phenobarbitone) until death but no information was available for the exact time 199 
interval for the other two. Finally, the three remaining dogs had poorly controlled ES and were 200 
euthanased by the referring veterinarians. One was euthanased 12 months later during status 201 
epilepticus (CSF analysis had revealed TNCC of 6 cell/µl and protein concentration of 0.36g/l). 202 
The second was euthanased whilst in status epilepticus (CSF analysis had revealed 203 
albuminocytological dissociation with CSF protein of 0.31g/l) due to the owner’s request 204 
approximately 3 months after discharge. The survival time for the last case was not possible to 205 
determine through the referring veterinarian’s records but euthanasia was performed following 206 
an episode of status epilepticus; CSF analysis had revealed albuminocytological dissociation 207 
with CSF protein of 0.38g/l. 208 
Within our study population, only one dog had a suspected diagnosis different from IE.  209 
This patient was diagnosed with suspected metaldehyde intoxication based on the owners’ 210 
report of likely exposure and exclusion of other possible causes through the diagnostic 211 
investigations (unremarkable haematology and biochemistry profiles, bile acid stimulation, 212 
MRI of the brain and CSF analysis) as well as based on the lack of recurrent ES over a follow-213 
up period of 27 months (without receiving antiepileptic medication). In view of these results, 214 
the prevalence for a diagnosis other than IE in this study population of dogs was 0.5% (1/200, 215 
95% CI 0.09 – 2.78%); it should be highlighted that CSF analysis in this patient was normal.  216 
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 217 
Discussion 218 
Dogs that develop ES are often neurologically normal when examined in the interictal 219 
period. A Tier II confidence level for the diagnosis of IE is usually desirable and commonly 220 
pursued in a referral setting. After exclusion of a systemic disease that might trigger reactive 221 
seizures, an MRI study is performed. The likelihood of MR imaging identifying structural 222 
abnormalities has been shown to be low in dogs less than 6-years-old (2.2%) but relatively high 223 
in those older than that age (26.7%).6 Obtaining a CSF sample for analysis is commonly 224 
performed regardless of the results of previous tests in order to conclusively exclude a possible 225 
infectious or inflammatory condition. It should nonetheless be taken into account that this 226 
procedure can be associated with significant complications such as iatrogenic brainstem or 227 
spinal cord trauma,12 13 14 prolonging anaesthesia time and increasing cost. Our results suggest 228 
that performing CSF analysis did not increase the diagnostic sensitivity on a population of 229 
epileptic dogs with no interictal abnormalities and unremarkable MRI of the brain.  230 
In 15% of our cases (30 cases), mild abnormalities were found on CSF analysis. Despite 231 
this, a diagnosis of IE was made based on otherwise unremarkable diagnostic investigations 232 
and lack of interictal neurological abnormalities. Most of these cases (20/26) showed an 233 
improvement in the ES frequency and no neurological deficits during a median follow-up time 234 
of 32 months. Four cases were lost to follow up, three died due to unrelated causes and three 235 
were euthanased due to poorly controlled ES. It was not thought likely but it is possible that 236 
some of the patients with CSF abnormalities had a cause for the ES other than IE (either reactive 237 
or structural) but without histopathology this is impossible to conclusively establish.  238 
Epileptic seizures have been suggested to cause alterations in the CSF.8 A previous 239 
study8 reported an association between the CSF TNCC and seizures, with the TNCC tending to 240 
decrease as the length of time between the last ES and CSF collection increased. A transient 241 
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disturbance of the blood-brain barrier has been demonstrated in experimental animals following 242 
ES15 and has been suggested as a possible explanation for changes in the composition of CSF 243 
following ES in humans16. In our study, we found no association between abnormal CSF protein 244 
concentration or TNCC and the time interval between ES episode and CSF collection. These 245 
results would suggest that ES are unlikely to significantly alter the composition of CSF. Studies 246 
performed in humans revealed that ES-induced CSF abnormalities are uncommon,17 18 but mild 247 
increases in protein concentration and TNCC can be seen in up to 34% and 10% respectively 248 
of human patients after seizures.19 20 249 
Status epilepticus has been found to be more frequently associated with structural epilepsy and 250 
reportedly occurred in 28% of IE cases compared to 64% of cases with structural epilepsy.21 251 
Single ES versus cluster seizures have been reported as less likely to have an asymmetrical 252 
structural lesion of the brain.7 In the present study cluster seizures were documented in 56 dogs 253 
(28%) and status epilepticus in only 2 dogs (1%). No association between ES semiology (focal 254 
or generalised) or occurrence of clusters seizures and the composition of the CSF was found.  255 
CSF does not normally contain erythrocytes. The presence of erythrocytes is most 256 
commonly iatrogenic or in some cases associated with a pathological subarachnoid 257 
haemorrhage.9 Peripheral blood contamination is a common confounding problem in CSF 258 
collection independent of technique. The impact of CSF blood contamination is not clear and 259 
the current literature on the subject is conflicting. The effect of blood contamination on CSF 260 
protein concentration is controversial with some studies showing that samples with RBC counts 261 
of 5,000–10,000/µl did not have significantly increased CSF protein22 23 whilst others showed 262 
a mild but statistically significant increase in CSF samples with RBC counts >500/µl.23 263 
Similarly, a significant effect of blood contamination on CSF TNCC has been demonstrated in 264 
some studies when RBC counts ranged from 250/µl to 1,500/µl 24 but not in others.25. In our 265 
study the number of RBCs on CSF was significantly associated with having an abnormal CSF 266 
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analysis. We found that blood contamination was moderately correlated with the CSF TNCC 267 
and weakly with the CSF protein concentration. This may have been related to the overall low 268 
blood contamination in our study as no association between CSF RBC and protein 269 
concentration was found when contamination was <500/µl.23  270 
Several formulae to help estimate the effects of blood contamination on CSF cellularity 271 
and protein concentration have been suggested10 11 with the authors commenting that these 272 
likely overestimate the effects of peripheral blood contamination and that they may be useful 273 
when attempting to confirm disease but should not be used to rule out pathology. When the 274 
suggested formulae were used in the present study, the correlation between TNCC and CSF 275 
RBC contamination weakened, suggesting that blood contamination does interfere with the 276 
CSF analysis results.  277 
This study suggests that performing CSF analysis in dogs with recurrent ES that have a 278 
normal interictal neurological examination and unremarkable MRI does not increase the 279 
likelihood of detecting an underlying cause. 280 
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Table 1. Associations between abnormal CSF analysis and different independent variables  377 
 Statistic test p-value 
Type of ES: 
- Generalised or Focal 
 
Fisher’s exact test 
 
p=0.68 
Number of ES: 
- ≤ 5 or  >5 
 
Pearson’s Chi-square test 
 
p=0.55 
Cluster ES Fisher’s exact test p=0.38 
Status epilepticus Fisher’s exact test p=0.28 
Time interval between last ES 
and CSF analysis 
Pearson’s Chi-square test  
 
p=0.92 
 
CSF collection site:  
CMC or LSS  
 
Fisher’s exact test 
 
p=0.11 
Number of RBCs on CSF Mann-Whitney test p<0.000 
 378 
CSF -  Cerebrospinal Fluid; CMC - Cerebellomedullary Cistern; ES – epileptic seizure; LSS - 379 
Lumbar subarachnoid space; RBC - Red Blood Cell.  380 
 16 
Table 2. Correlations between CSF parameters and CSF blood contamination  381 
 Correlation coefficient p-value 
CSF TNCC and CSF RBC count Spearman Rho: 0.427 p<0.000 
Corrected CSF TNCC* and CSF RBC count Spearman Rho: 0.237 p=0.257 
CSF protein concentration and CSF RBC count Spearman Rho: 0.253 p=0.0001 
Corrected CSF protein concentration§ and CSF 
RBC count 
Spearman Rho: 0.248 p=0.0001 
CSF - Cerebrospinal Fluid; TNCC - Total Nucleated Cell Count; RBC - Red Blood Cell. 382 
*CSF TNCC increased by 1 nucleated cell/μl for every 500 RBC/μl 383 
§CSF protein concentration increased by 0.01g/L for every 1,000 RBC/μl of CSF   384 
 17 
Table 3. Correlations between CSF blood contamination and CBC parameters  385 
 Correlation coefficient p-value 
CBC WBC count and CSF RBC count  Spearman Rho: 0.110 p=0.160 
CBC WBC count and CSF TNCC  Spearman Rho: 0.277 p=0.025 
CBC WBC count and CSF protein concentration Spearman Rho: 0.135 p=0.084 
CBC RBC count and CSF RBC count Spearman Rho: -0.029 p=0.710 
CBC RBC count and CSF TNCC Spearman Rho: -0.120 p=0.332 
CBC RBC count and CSF protein concentration Spearman Rho: 0.011 p=0.894 
 386 
CSF - Cerebrospinal Fluid; TNCC - Total Nucleated Cell Count; RBC - Red Blood Cell; WBC 387 
- White Blood Cell. 388 
